Cellular
-
Spine
Orthofix Announces Publication of Data Demonstrating the Clinical Benefits of Trinity Elite Cellular Bone Allograft in Lumbar Fusion Procedures
LEWISVILLE, TEXAS, December 22, 2022 –(BUSINESS WIRE)– Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and…
Read More » -
Biologics
SeaSpine Announces Publication of Results from a Cellular Bone Graft Study in The Journal of Bone and Joint Surgery (JBJS)
CARLSBAD, Calif., Nov. 03, 2020 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Biologics
Royal Biologics announces the launch of MAGNUS, a DMSO-free viable cellular bone allograft
JANUARY 08, 2020 Royal Biologics, an ortho-biologics company specializing in the research and advancement of regenerative cellular therapy and novel…
Read More » -
Biologics
LifeNet Health Expands Operations in the Pacific Northwest to Include Production of ViviGen® Cellular Bone Matrix
January 10, 2017 RENTON, Wash.–(BUSINESS WIRE)–LifeNet Health, the only full-service, non-profit tissue bank operating in the Pacific Northwest, has begun…
Read More » -
Spine
Orthofix Announces Publication of Data Demonstrating Benefits of Trinity Evolution Cellular Bone Allograft in Patients Undergoing Anterior Cervical Discectomy
July 27, 2016 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix International N.V. (NASDAQ: OFIX), a diversified, global medical device company, today announced the print…
Read More » -
Biologics
Preclinical Study Validates Science Behind AlloSource’s AlloStem Cellular Bone Allograft
CENTENNIAL, Colo., July 6, 2016 /PRNewswire-USNewswire/ — AlloSource, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for…
Read More » -
Financial
Cellular Biomedicine Group Announces Closing of $43.13 Million Strategic Investment from Dangdai International Group Co., Limited, a Wholly-Owned Hong Kong Subsidiary of Wuhan Dangdai Science & Technology Industries Group Inc.
SHANGHAI, China and CUPERTINO, Calif., April 19, 2016/GlobeNewswire/ — Cellular Biomedicine Group Inc. (NASDAQ: CBMG) (“CBMG” or the “Company”), a…
Read More »